Skip to content
healthcare.dev
Get a free key

Ruxience

NDC 0069-0249, rituximab-pvvr, injection, solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0249
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761103
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0249 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RITUXIMAB500 mg/50mL

Pharmacologic classes

CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
0069-0249-01000690249011 VIAL, SINGLE-USE in 1 CARTON (0069-0249-01) / 50 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f941fc61-f7a3-4e4a-ab7c-87c1667fa05b

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0069-0249

Use it

Look up 0069-0249 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0249 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0249. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.